Medsource 
Dealstreet

ELP acts on Medsource fund raise from private equity firm Xponentia Capital Partners

Pursuant to the fundraise Xponentia holds a minority stake in Medsource.

Bar & Bench

Leading In-Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals Private Limited has raised an undisclosed amount from private equity firm Xponentia Capital Partners (Xponentia).

Economic Laws Practice advised Xponentia. The team included Partner Abhishek Sanyal and Senior Associate Jishnu Dhar and Associate Daryl Menezes.

Pursuant to this fundraise Xponentia holds a minority stake in Medsource.

Medsource is one of India’s largest manufacturers of IVD products supplying specialized products to labs pan-India as well exporting to over 35+ countries.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court seeks action plan to stop untreated sewage flow into Yamuna

Strategic legal risk governance in India Inc: A jurisprudence-driven corporate imperative

Everything can't be left to judiciary: Justice Manmohan on implementing disability rights

Supreme Court directs Centre to trace Russian woman who fled India with her four-year-old child

Prajwal Revanna sentenced to life imprisonment in rape case

SCROLL FOR NEXT